Collection entries

human mouse mixed

PaperOne-sentence claimStudy typeLimitationTags
HArumugam et al., 2011, Naturegut-microbiome, enterotypes, bacteroides, prevotella, ruminococcus
?Belzer et al., 2017, mBioAkkermansia muciniphila cross-feeds mucin-derived substrates to butyrate producers including Faecalibacterium prausnitzii, the taxa can coexist and support each other ecologically rather than acting as simple opposites.Co-culture mechanistic studyIn vitro co-cultures; relative abundance on consumer reports does not prove cross-feeding activity in vivoakkermansia, faecalibacterium, cross-feeding, butyrate, synthesis
HBlack et al., 2022, GutNetwork meta-analysis of IBS dietary RCTs ranked low-FODMAP first for global symptom improvement and abdominal bloating/distension vs habitual and several comparator diets.Network meta-analysisMostly short trials; dietitian delivery varies; long-term data limitedbloating, fodmap, ibs, meta-analysis, diet
HBulygin et al., 2021, bioRxivgut-microbiome, enterotypes, dimensionality-reduction, clustering, 16s-rrna, metagenomics, american-gut-project, human-microbiome-project
HBulygin et al., 2023, PeerJEnterotype classifications, such as those reported by consumer gut microbiome tests, are likely artificial labels imposed on what is actually a smooth, continuous spectrum of variation; no matter what your test says, your gut microbiome probably doesn't neatly belong to one distinct biological 'type'.Computational reanalysis (human metagenomics)This study only addresses whether gut microbiome 'types' are real as discrete categories, it does not mean that the ratio of certain gut bacteria (like Prevotella vs Bacteroides) is useless. Those ratios may still turn out to be meaningful markers for health and diet, even if the hard boundaries between 'types' are not.gut-microbiome, enterotypes, dimensionality-reduction, clustering, 16s-rrna, metagenomics, american-gut-project, human-microbiome-project
HCamilleri et al., 2023, Am J Gastroenterol (ACG constipation guideline)ACG guidance on chronic idiopathic constipation recommends pathophysiology-based evaluation (transit vs outlet dysfunction) and evidence-supported fibre, osmotic laxatives, and pelvic floor biofeedback rather than unvalidated testing alone.GuidelineGuideline synthesis; access to manometry and transit tests variesconstipation, motility, guidelines, pelvic-floor
+Cani et al., 2007, DiabetesHigh-fat feeding raises plasma LPS in mice and humans; metabolic endotoxemia via TLR4 signalling links gut barrier permeability to obesity and insulin resistance in models.Mechanistic human + mouseRodent diets and acute human meal challenges; causality in free-living humans incompletelps, endotoxemia, metabolic, obesity, barrier
HCostea et al., 2018, Nature Microbiologygut-microbiome, enterotypes, gradients, clustering
HDepommier et al., 2017, Nature MedicinePasteurized A. muciniphila supplementation improved insulin sensitivity in overweight adults.RCT (human)Small sample; specific preparation and dose; not a consumer stool test endpointakkermansia, intervention, metabolism
HDuvallet et al., 2017, Nature Communications verifiedRe-analysis of 28 case–control 16S studies shows most disease-associated microbiome shifts are shared across conditions, not disease-specific. Alpha diversity falls reliably in diarrhoea and perhaps IBD, but not in obesity or most other diseases. Enrichment of a few pathogens (e.g. CRC) contrasts with depletion of health-associated Clostridiales in IBD; ~51% of genus associations recur in more than one disease.Meta-analysis16S amplicon studies only; disease heterogeneity within categories; antibiotic use and symptom overlap (e.g. diarrhoea) confound many associations; genus-level resolution cannot resolve strain-level pathogenic vs commensal rolesalpha-diversity, meta-analysis, dysbiosis, ibd, crc, diarrhea, confounding, methodology, interpretation
MEverard et al., 2013, PNASObese mice had lower A. muciniphila abundance, and restoring it improved metabolic markers.Preclinical (mouse)Animal model; not direct evidence for human test interpretationakkermansia, obesity, metabolism
HFord et al., 2019, Gut (probiotics for IBS network meta-analysis)Network meta-analysis of probiotics in IBS shows benefit for some endpoints but substantial heterogeneity between strains, no single probiotic class effect.Meta-analysisTrial quality varies; strain formulations differ from consumer productsprobiotics, ibs, meta-analysis
HFranzosa et al., 2019, Cell Host & MicrobeLongitudinal metagenomics in adults shows person-specific microbiome signatures that persist over time, supporting individualized baselines rather than one universal healthy template for dysbiosis scoring.Longitudinal cohortRelative abundance focus; functional measures add complementary signaldysbiosis, personalization, longitudinal, interpretation
HHalmos et al., 2014, GastroenterologyCrossover trial in IBS: a low-FODMAP diet reduced overall GI symptoms, bloating, pain, and wind vs a typical Australian diet; controls were unaffected.Randomized crossover feeding trialShort-term controlled diet; not all real-world FODMAP trials match designbloating, fodmap, ibs, fermentation, hydrogen
HHill et al., 2014, Nat Rev Gastroenterol Hepatol (ISAPP probiotics)ISAPP consensus defines probiotics as live microorganisms conferring health benefits at adequate doses and stresses that benefits are strain-specific, not genus-level.GuidelineConsensus definition; does not rate individual commercial productsprobiotics, isapp, bifidobacterium, lactobacillus
HHooks & O'Malley, 2017, mBioCommentary arguing that "dysbiosis" is an imprecise ecological descriptor, not a standalone diagnosis, and that microbiome studies need clearer mechanistic hypotheses than deviation from a reference community.ReviewCommentary; does not define vendor scoring algorithmsdysbiosis, interpretation, methodology
HHuman Microbiome Project Consortium, 2012, NatureHealthy human gut microbiomes are highly variable between individuals but stable within individuals over time.Observational cohort2012 sequencing depth and methods; limited diversity samplingdiversity, baseline, methodology
HImhann et al., 2016, SciencePopulation cohort links many non-antibiotic drugs, including PPIs, metformin, and laxatives, to characteristic shifts in gut microbiome composition.Observational cohortAssociation not causation; medication indication confoundsmedications, ppi, metformin, drug-microbiome
HJeffery et al., 2012, Nature Reviews MicrobiologyThe neat division of gut microbiomes into distinct enterotypes may be an oversimplification, the data more likely reflects a continuous gradient running from Bacteroides-dominated to Prevotella-dominated communities, with no clean boundaries in between.Expert commentary / narrative reviewThis paper questions the discreteness of enterotypes but does not itself provide new experimental data, it is a conceptual reappraisal of existing studies, and the authors acknowledge that linking microbiome composition patterns to clinical outcomes remains a worthwhile and open goal, regardless of whether those patterns are gradients or clusters.gut-microbiome, enterotypes, bacteroides, prevotella, ruminococcus, microbiome-gradients, 16s-rrna, diet, ageing, co-abundance-groups
MJohansson et al., 2011, PNASColon mucus is organized into inner and outer MUC2 layers; the inner layer is largely bacteria-free in health and forms a critical physical barrier.ObservationalMouse model; human mucus architecture broadly similar but not identicalmucus, muc2, intestinal-barrier, colon
HKnights et al., 2014, Cell Host & Microbegut-microbiome, enterotypes, clustering, longitudinal, methodology
HLacy et al., 2021, Am J Gastroenterol (ACG IBS guideline)ACG guidance on IBS management emphasises identifying alarm features, selective diagnostic testing, and evidence-based dietary and pharmacologic options rather than unvalidated microbiome-based protocols.GuidelineGuideline synthesis; individual patient workup varies by health systemibs, red-flags, clinical-care, guidelines
+Langille et al., 2013, Nature BiotechnologyMetagenomic gene content can predict microbial community metabolic profiles using reference genome databases, supporting pathway inference while highlighting database completeness limits.Methods / validationReference-genome-dependent; human stool validation subset onlymetagenomics, pathways, functional-profiling, prediction
HLopez-Siles et al., 2018, Front Cell Infect MicrobiolAkkermansia muciniphila and Faecalibacterium prausnitzii co-occur in mucosal microbiota; both can be altered in IBD but are not mutually exclusive markers of health vs disease in individuals.Observational (mucosal biopsies)IBD cohort; stool reports may not reflect mucosal co-occurrenceakkermansia, faecalibacterium, ibd, co-occurrence, synthesis
HLouis & Flint, 2017, Environ MicrobiolReviews how human colonic bacteria form propionate and butyrate via distinct pathways, including acetate-dependent butyrate production requiring cross-feeding partners.ReviewPathway focus; does not quantify individual SCFA output from consumer testsscfa, butyrate, propionate, cross-feeding
HLozupone et al., 2012, NatureGut microbial communities vary widely between individuals and over time; alpha diversity (within-sample richness/evenness) must be interpreted with ecological context including diet, age, and disease state.ReviewPre–shotgun-metagenomics era; conceptual framework more than clinical thresholdsalpha-diversity, ecology, beta-diversity, stability
HLozupone et al., 2013, Genome ResearchCross-study meta-analysis shows technical variables (16S region, extraction, platform) can bias observed alpha diversity as much as or more than some biological effects.Meta-analysis2013 methods; still relevant for interpreting single-lab consumer scoresalpha-diversity, meta-analysis, methodology, 16s
HMajor et al., 2017, GastroenterologyIBS patients and healthy controls produce similar colonic gas after inulin or fructose challenges; symptom differences reflect colonic hypersensitivity to distension, not excess fermentation alone.Randomized crossover (MRI + breath hydrogen)Small cohort; challenge drinks not full dietary patternsbloating, fodmap, visceral-hypersensitivity, fermentation, ibs
HMarshall et al., 2019, NutrientsSystematic review estimates roughly 7–15% of post-gastroenteritis patients develop IBS at 3–12 months, with severity and psychological factors influencing risk.Systematic reviewHeterogeneous primary studies and pathogen definitionspi-ibs, post-infectious, ibs, gastroenteritis
HMassier et al., 2021, GutWidely used commercial zonulin ELISAs may not measure prehaptoglobin-2 and correlate poorly with gold-standard permeability tests, undermining many ELISA-based leaky-gut claims.ReviewFocuses on assay validity; does not negate all permeability biologyzonulin, intestinal-barrier, permeability, biomarker
HMoayyedi et al., 2014, Am J GastroenterolMeta-analysis of fiber supplementation in IBS found soluble gel-forming fiber (psyllium) beneficial for global symptoms; insoluble wheat bran did not show significant benefit.Meta-analysisHeterogeneous trials; fiber types and doses variedfiber, ibs, psyllium, meta-analysis
HOliphant & Allen-Vercoe, 2019, Nat Rev MicrobiolCross-feeding between gut microbes, acetate and lactate donors feeding butyrate and propionate producers, explains why single-taxon interventions often fail to shift SCFA profiles predictably.ReviewMechanistic review; human dose-response varies by communitycross-feeding, scfa, butyrate, bifidobacterium
HPalleja et al., 2018, Nature MicrobiologyIn healthy adults, common antibiotics acutely reduce gut microbiome diversity; species richness often returns toward baseline within weeks to months, but compositional and functional differences can persist for at least six months.Longitudinal interventionHealthy volunteers, not patients; antibiotic regimens differ from all clinical usealpha-diversity, antibiotics, recovery, longitudinal
HPimentel et al., 2014, GastroenterologyMethane on breath testing associates with constipation-predominant IBS and slower transit; methanogenesis acts as a hydrogen sink altering colonic fermentation.Review / mechanistic synthesisBreath-test populations; not all constipation is methane-drivenmethane, ibs-c, constipation, breath-testing, methanogens
HRinninella et al., 2019, MicroorganismsThere is no single "healthy" gut microbiome template; diversity and composition vary widely among asymptomatic people by diet, geography, and lifestyle.ReviewNarrative review; does not define consumer-test optimal rangesalpha-diversity, dysbiosis, healthy-microbiome, interpretation
MSchroeder et al., 2018, Cell Host & MicrobeIn mice, low microbiota-accessible carbohydrates erode colonic mucus; dietary fiber or Bifidobacterium supplementation protected mucus thickness.InterventionMouse diet model; human dose and community differfiber, mucus, bifidobacterium, intestinal-barrier, mac
HSokol et al., 2008, PNASFaecalibacterium prausnitzii produces anti-inflammatory metabolites and is reduced in some IBD cohorts, an association, not a diagnostic threshold for individuals.ObservationalCohort associations; abundance varies with diet and sequencing methodfaecalibacterium, ibd, inflammation, scfa
HSonnenburg & Sonnenburg, 2014, Cell MetabolismDiets low in microbiota-accessible carbohydrates deplete fiber-degrading taxa and reduce fermentation capacity, framing the long-term cost of low-fiber Western diets.ReviewNarrative synthesis; MAC availability is person-specificfiber, mac, dysbiosis, scfa
HSperber et al., 2017, Neurogastroenterol Motil (Rome IV overview)Rome IV defines functional GI disorders by symptom-based criteria and distinguishes them from organic disease when alarm features are absent or adequately investigated.GuidelineSymptom-based criteria; does not replace endoscopy or serology when indicatedrome-iv, ibs, functional-gut, red-flags
HSpiller & Garsed, 2009, Postgrad Med JPost-infectious IBS involves persistent motility, immune, and sensory changes after gastroenteritis; many patients improve over 12–24 months without targeted microbiome therapy.ReviewMechanistic synthesis; treatment trials limited at time of publicationpi-ibs, post-infectious, motility, mechanisms
HSu et al., 2020, Gastroenterology (AGA probiotics guideline)AGA guidance provides conditional recommendations for specific probiotic strains in selected indications and cautions against indiscriminate use.GuidelineConditional recommendations; evidence base evolvingprobiotics, guidelines, aga
HSuez et al., 2018, CellAfter antibiotics, autologous fecal microbiota transplant accelerated gut microbiome and mucosal gene expression reconstitution in this trial, whereas a multi-strain probiotic regimen delayed full recovery compared with spontaneous recovery.RCTSingle trial design; probiotic formulation and timing may not generalize to all productsantibiotics, probiotics, fmt, recovery, post-antibiotic
+Valdes et al., 2018, BMJDiet influences gut microbiome composition, but causal effects on long-term health outcomes remain incompletely defined.ReviewHeterogeneous primary studies; association-heavy fielddiet, interpretation, evidence-limits
HVilloria et al., 2011, Am J GastroenterolVisible abdominal distension in functional gut disorders often reflects abdominophrenic dyssynergia (diaphragmatic descent + abdominal wall relaxation), not necessarily increased intra-abdominal gas volume.Physiology / imaging cohortSpecialist centre; not all bloating is APDbloating, distension, abdominophrenic-dyssynergia, motility
+Windey et al., 2012, Molecular Nutrition & Food ResearchColonic protein fermentation yields branched-chain fatty acids, ammonia, and phenolic compounds distinct from saccharolytic SCFA production on fermentable carbohydrate.ReviewMostly in vitro and animal dose data; human clinical thresholds sparseprotein, bcfas, fermentation, scfa

One claim per study. Mixed, uncertain, or conflicting findings sit alongside stronger ones; nothing here is ranked or scored.